These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 34153521)

  • 21. COX-2/sEH Dual Inhibitor Alleviates Hepatocyte Senescence in NAFLD Mice by Restoring Autophagy through Sirt1/PI3K/AKT/mTOR.
    Zhang CY; Tan XH; Yang HH; Jin L; Hong JR; Zhou Y; Huang XT
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The S100 calcium-binding protein A11 promotes hepatic steatosis through RAGE-mediated AKT-mTOR signaling.
    Teng F; Jiang J; Zhang J; Yuan Y; Li K; Zhou B; Zhou X; Liu W; Zhang P; Liu D; Zheng M; Lu Y; Zhang H
    Metabolism; 2021 Apr; 117():154725. PubMed ID: 33571540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deletion of Smurf1 attenuates liver steatosis via stabilization of p53.
    Lin W; Zhang X; Zhang C; Li L; Zhang J; Xie P; Zhan Y; An W
    Lab Invest; 2022 Oct; 102(10):1075-1087. PubMed ID: 35672379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired Hepatic Vitamin A Metabolism in NAFLD Mice Leading to Vitamin A Accumulation in Hepatocytes.
    Saeed A; Bartuzi P; Heegsma J; Dekker D; Kloosterhuis N; de Bruin A; Jonker JW; van de Sluis B; Faber KN
    Cell Mol Gastroenterol Hepatol; 2021; 11(1):309-325.e3. PubMed ID: 32698042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mouse trefoil factor 3 ameliorated high-fat-diet-induced hepatic steatosis via increasing peroxisome proliferator-activated receptor-α-mediated fatty acid oxidation.
    Wu X; Zheng H; Yang R; Luan X; Zhang L; Jin Q; Jin Y; Xue J
    Am J Physiol Endocrinol Metab; 2019 Sep; 317(3):E436-E445. PubMed ID: 31211621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human germline hedgehog pathway mutations predispose to fatty liver.
    Guillen-Sacoto MJ; Martinez AF; Abe Y; Kruszka P; Weiss K; Everson JL; Bataller R; Kleiner DE; Ward JM; Sulik KK; Lipinski RJ; Solomon BD; Muenke M
    J Hepatol; 2017 Oct; 67(4):809-817. PubMed ID: 28645738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease
    Li CX; Gao JG; Wan XY; Chen Y; Xu CF; Feng ZM; Zeng H; Lin YM; Ma H; Xu P; Yu CH; Li YM
    World J Gastroenterol; 2019 Sep; 25(34):5120-5133. PubMed ID: 31558861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Geranylgeranyl diphosphate synthase (GGPPS) regulates non-alcoholic fatty liver disease (NAFLD)-fibrosis progression by determining hepatic glucose/fatty acid preference under high-fat diet conditions.
    Liu J; Jiang S; Zhao Y; Sun Q; Zhang J; Shen D; Wu J; Shen N; Fu X; Sun X; Yu D; Chen J; He J; Shi T; Ding Y; Fang L; Xue B; Li C
    J Pathol; 2018 Nov; 246(3):277-288. PubMed ID: 29971772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GLP-1 analogue improves hepatic lipid accumulation by inducing autophagy via AMPK/mTOR pathway.
    He Q; Sha S; Sun L; Zhang J; Dong M
    Biochem Biophys Res Commun; 2016 Aug; 476(4):196-203. PubMed ID: 27208776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Silencing of STE20-type kinase MST3 in mice with antisense oligonucleotide treatment ameliorates diet-induced nonalcoholic fatty liver disease.
    Caputo M; Kurhe Y; Kumari S; Cansby E; Amrutkar M; Scandalis E; Booten SL; Ståhlman M; Borén J; Marschall HU; Aghajan M; Mahlapuu M
    FASEB J; 2021 May; 35(5):e21567. PubMed ID: 33891332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone morphogenetic protein 4 (BMP4) alleviates hepatic steatosis by increasing hepatic lipid turnover and inhibiting the mTORC1 signaling axis in hepatocytes.
    Peng Q; Chen B; Wang H; Zhu Y; Wu J; Luo Y; Zuo G; Luo J; Zhou L; Shi Q; Weng Y; Huang A; He TC; Fan J
    Aging (Albany NY); 2019 Dec; 11(23):11520-11540. PubMed ID: 31831718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatocyte-secreted FAM3D ameliorates hepatic steatosis by activating FPR1-hnRNP U-GR-SCAD pathway to enhance lipid oxidation.
    Hu Y; Li J; Li X; Wang D; Xiang R; Liu W; Hou S; Zhao Q; Yu X; Xu M; Zhao D; Li T; Chi Y; Yang J
    Metabolism; 2023 Sep; 146():155661. PubMed ID: 37454871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fatty Acids Activate the Transcriptional Coactivator YAP1 to Promote Liver Fibrosis via p38 Mitogen-Activated Protein Kinase.
    Salloum S; Jeyarajan AJ; Kruger AJ; Holmes JA; Shao T; Sojoodi M; Kim MH; Zhuo Z; Shroff SG; Kassa A; Corey KE; Khan SK; Lin W; Alatrakchi N; Schaefer EAK; Chung RT
    Cell Mol Gastroenterol Hepatol; 2021; 12(4):1297-1310. PubMed ID: 34118488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fatty acids promote fatty liver disease via the dysregulation of 3-mercaptopyruvate sulfurtransferase/hydrogen sulfide pathway.
    Li M; Xu C; Shi J; Ding J; Wan X; Chen D; Gao J; Li C; Zhang J; Lin Y; Tu Z; Kong X; Li Y; Yu C
    Gut; 2018 Dec; 67(12):2169-2180. PubMed ID: 28877979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of LXR signaling by SULT2B1b promotes liver regeneration after partial hepatectomy in mouse models of nonalcoholic fatty liver disease.
    Zhang X; Xu Y; Bai Q; Li X; Han J; Hou Y; Ji Y; Zhang Z
    Am J Physiol Gastrointest Liver Physiol; 2020 Jul; 319(1):G87-G96. PubMed ID: 32475129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.
    Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X
    EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Different Mechanisms of Lipid Accumulation in Hepatocytes Induced by Oleic Acid/Palmitic Acid and High-Fat Diet.
    Zhang M; Bai X; Du Q; Xu J; Wang D; Chen L; Dong K; Chen Z; Yang J
    Molecules; 2023 Sep; 28(18):. PubMed ID: 37764494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bempedoic Acid Unveils Therapeutic Potential in Non-Alcoholic Fatty Liver Disease: Suppression of the Hepatic PXR-SLC13A5/ACLY Signaling Axis.
    Sun Q; Guo Y; Hu W; Zhang M; Wang S; Lei Y; Meng H; Li N; Xu P; Li Z; Lin H; Huang F; Qiu Z
    Drug Metab Dispos; 2023 Dec; 51(12):1628-1641. PubMed ID: 37684055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adipogenic changes of hepatocytes in a high-fat diet-induced fatty liver mice model and non-alcoholic fatty liver disease patients.
    Pan X; Wang P; Luo J; Wang Z; Song Y; Ye J; Hou X
    Endocrine; 2015 Apr; 48(3):834-47. PubMed ID: 25138963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased PEDF Promotes Hepatic Fatty Acid Uptake and Lipid Droplet Formation in the Pathogenesis of NAFLD.
    Huang KT; Chen KD; Hsu LW; Kung CP; Li SR; Chen CC; Chiu KW; Goto S; Chen CL
    Nutrients; 2020 Jan; 12(1):. PubMed ID: 31968655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.